Clinical imaging in regenerative medicine

Area of Science:

• Regenerative Medicine
• Medical Imaging
• Cell Therapy

Background:

• Clinical imaging is vital for assessing tissue damage and evaluating cell therapy safety and efficacy.
• Current imaging methods struggle with long-term tracking of transplanted cells, with exogenous labels being unreliable and genetic labels posing regulatory and safety concerns in humans.

Purpose of the Study:

• To highlight the challenges in current cell tracking technologies for regenerative medicine.
• To identify key areas for future research in developing improved imaging labels for cell therapies.

Main Methods:

• Review of current limitations in exogenous and genetically encoded cell labels for clinical imaging.
• Discussion of common challenges in imaging studies across different organs (brain, heart, islets).

Main Results:

• Existing imaging techniques have limited ability to track transplanted cell fate and function long-term.
• Exogenous labels lack long-term reliability, while genetic labels raise safety and immunogenicity concerns in humans.

Conclusions:

• Novel labeling approaches are needed to enhance detection thresholds and assess toxicity and function early.
• Future research must address safety of genetic labels and develop methods to monitor cell survival, differentiation, and integration.
• Advanced imaging can elucidate cell therapy mechanisms and bridge the gap to improved health outcomes.